glp 1 zepbound tirzepatide Zepbound: How It Works, How to Inject It, and Side Effects Tirzepatide (Zepbound)
Description
Mounjaro is not appropriate for all patients

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (under the brand name Zepbound)

Semaglutide It is a GLP-1 receptor agonist that mimics the bodys natural hormone

So far i have lost 20lbs in 10 weeks and i am on the lowest dose (2.5)
2024;20 6 Suppl:S989

Am J Emerg Med 2009;27(4):509-10
